Key result
Aging-associated autoreactive memory CD4+ T cells may drive atherosclerosis and represent a novel therapeutic target.
Answers are grounded in this paper and cite their sources.
Introduction: With age, the proportion of memory T cells increases, while the proportion and number of naive T cell decreases. Memory T cells are more sensitive to antigenic stimulation and less dependent on co-stimulation signals, as compared to naïve T cells. Differentiation of naïve T cells into memory T cells is accompanied by an increase in T cell reactivity to self-peptide/MHC complexes, which allowed for positive selection of their naïve precursors in the thymus.Areas covered: We envisage that in geriatric age memory Th1-type autoreactivity leads to age-associated immune hyporeactivity, atherosclerosis, and degenerative neuropathology, such as Alzheimer’s and Parkinson’s diseases, whereas autoreactive memory Th2 cells could promote tumorigenesis.Expert option: Stimulation of adaptive immunoregulatory mechanisms by polyclonal T-cell vaccination could constrain the development of age-related T-cell autoreactivity surplus. Another approach to immune system ‘rejuvenation’ could involve adoptive cell transfer of naïve T cells with a view to restrain the expansion of pathological memory T cells and support immune responsiveness to novel antigenic challenges. The proposed concept conjectures the occurrence of a hard-wired immunological clock that could determine the duration of life, which theoretically could be subject to immune-based therapy.
No takes yet. Share an insight, caveat, or question.
Селедцов et al. (2020) conducted a review in Age-related immune abnormalities, atherosclerosis, degenerative neuropathology, and tumorigenesis. Memory CD4+ T-cell autoreactivity in aging is hypothesized to drive atherosclerosis, neurodegeneration, and tumorigenesis, potentially targetable via T-cell vaccination or naive T-cell transfer.
Synapse has enriched 10 related papers. Consider them for comparative context: